Helix BioPharma (HBP) Stock Chart & Stock Price History C$0.97 0.00 (0.00%) As of 07/11/2025 09:34 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock Helix BioPharma Stock Price Performance The Helix BioPharma (HBP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 321.74%, with a year-to-date return of 8.99%. In the past month, the stock has increased 4.30%, reflecting recent market activity. As of the latest close, Helix BioPharma traded at C$0.97 with a market cap of C$51.43 million and volume of 1,357 shares. Five years ago, the stock traded at C$0.63, representing a 53.97% increase over that period. At the time, it had a market cap of C$86.41 million and a volume of 8,700 shares. Receive HBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month PerformanceN/A3 Month Performance+25.97%Year-To-Date Performance+8.99%1 Year Performance+321.74%5 Year Performance+53.97% HBP Stock Chart for Saturday, July, 12, 2025 HBP Chart by TradingView Helix BioPharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025C$0.97C$0.97C$0.97C$0.971,357 shsC$51.43 million07/08/2025C$0.97C$0.97C$0.97C$0.973,000 shsC$51.43 million07/07/2025C$0.97C$0.97C$0.97C$0.973,000 shsC$51.43 million07/04/2025C$0.97C$0.97C$0.97C$0.973,000 shsC$51.43 million07/03/2025C$0.97C$0.97C$0.97C$0.97500 shsC$51.43 million07/02/2025C$0.93C$0.97+4.30%C$0.97C$0.971,000 shsC$51.43 million07/01/2025C$0.93C$0.93C$0.93C$0.843,624 shsC$49.31 million06/30/2025C$0.95C$0.93-2.11%C$0.93C$0.843,624 shsC$49.31 million06/27/2025C$0.93C$0.95+2.15%C$0.95C$0.9319,100 shsC$50.37 million06/26/2025C$0.93C$0.93C$0.93C$0.932,000 shsC$49.31 million Get the Latest News and Ratings for HBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter. 06/25/2025C$0.93C$0.93C$0.93C$0.932,000 shsC$49.31 million06/24/2025C$0.93C$0.93C$0.93C$0.903,100 shsC$49.31 million06/23/2025C$0.90C$0.93+3.33%C$0.93C$0.911,000 shsC$49.31 million06/20/2025C$0.90C$0.90C$0.90C$0.90500 shsC$47.72 million06/19/2025C$0.92C$0.90-2.17%C$0.90C$0.901,000 shsC$47.72 million06/18/2025C$0.91C$0.92+1.10%C$0.92C$0.92500 shsC$48.78 million06/17/2025C$0.91C$0.91C$0.92C$0.911,600 shsC$48.25 million06/16/2025C$0.93C$0.91-2.15%C$0.92C$0.911,500 shsC$48.25 million Related Companies Theratechnologies Stock Chart Oncolytics Biotech Stock Chart Covalon Technologies Stock Chart Medicenna Therapeutics Stock Chart Aptose Biosciences Stock Chart Sernova Stock Chart Microbix Biosystems Stock Chart Hemostemix Stock Chart Devonian Health Group Stock Chart Sirona Biochem Stock Chart Receive HBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:HBP) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix BioPharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helix BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
